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accurately predict the natural history of any individual renal artery
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Thomas L. Forbes, MD, and Jean-Baptiste Ricco, MD, PhD, London, Ontario, Canada;
and Poitiers, France
It was expected that information resulting from recently com-
pleted randomized controlled trials would clarify the role of renal
artery interventions in patients with atherosclerotic renal artery
stenoses. Unfortunately, in this respect, we were left disappointed.
Concerns regarding such issues as inclusion criteria limited the
validity of these studies’ conclusions, leaving a persistent knowl-
edge gap into which our debaters step.
Although the authors were given separate charges, their con-
clusions are more similar than different. They both recognize the
need for further study and information to elucidate the role of renal
artery interventions. They recognize that we currently cannotatient’s hypertension or renal insufficiency. So instead of recom-
ending whether the majority or the minority of patients should
e intervened upon, they appropriately meet somewhere in the
iddle.
With the present uncertainty, the authors propose a multidis-
iplinary, collaborative approach to these often complicated clini-
al situations to arrive at decisions regarding individual patients.
hey propose a more aggressive approach in patients with specific
riteria, including progressive hypertension, renal insufficiency
ith flash pulmonary edema, bilateral severe renal artery stenoses,
nd stenoses with a solitary kidney. Until further information is
opefully obtained from ongoing trials, this selective approach
eems reasonable and most prudent.
